MTaI is an association of research-based medical technology companies who have made remarkable investments by setting up large number of R&D centres and manufacturing plants in India. MTaI represents a wide spectrum of the medical device and equipment industry with global experience in innovation and manufacturing.
All the time stressing on the three hallmarks of healthcare – Quality, Consistency and Patient Safety, we want to be a responsible voice of the industry. We are committed to improving access to affordable and quality healthcare for patients… Read More
The Union government has notified a set of new rules to regulate the medical device sector – worth thousands of crores and growing. For the first time, the rules will make a distinction between medical devices and drugs and pharmaceuticals, creating separate standards...read more
The health ministry's medical devices rules still deviate from globally accepted practices, insisting on conditions like different labelling requirements and shorter expiry dates for the products, argue global medical device makers upset with the third draft of the...read more
The multinational medical technology majors are seeking the authorities to remove regulatory hurdles for importing pre-owned medical equipment to the country. While these companies manufacture in India and support the Centre's initiatives to promote manufacturing of...read more
The medical devices industry remains bitterly divided even as the Centre looks to regulate import of pre-owned products Away from the glare of very public discussions on stents, a device used largely in the heart, another debate engulfs the medical devices...read more
The center-right government of Indian Prime Minister Narendra Modi says it has the medical devices sector squarely in its sights as one of its priority “Make in India” sectors to boost domestic manufacturing and spur job creation, and global medical device makers are...read more
Contemporary bare-metal stents are as good as drug-eluting stents—their newer generation counterparts—a new Norwegian study on over 9,000 patients has found. The observation comes at a time when India has decided to clamp price controls on stents and the government is...read more